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Introduction
Oocytes arrest at metaphase of the second meiotic division 
(MetII) before fertilization because of an activity termed cyto-
static factor (CSF; Masui, 2000; Tunquist and Maller, 2003; 
Jones, 2005). Sperm break this arrest via a Ca
2+ signal (Jones, 
1998; Stricker, 1999; Runft et al., 2002), and in so doing, oo-
cytes complete the second meiotic division before entering the 
embryonic cell cycles.
CSF activity, a terminology that was fi  rst defi  ned several 
decades ago (Masui and Market, 1971), is now known to consti-
tute an inhibitor of the anaphase-promoting complex/cyclosome 
(APC; Tunquist and Maller, 2003). The APC is an E3 ubiquitin 
ligase whose activity is required for the metaphase–anaphase 
transition to polyubiquitinate key cell cycle proteins, thereby 
earmarking them for immediate proteolysis through associa-
tion with its key coactivator cdc20 (Fang et al., 1998; Kramer 
et al., 1998; Harper et al., 2002; Eytan et al., 2006). The reduced 
APC
cdc20 activity in MetII oocytes prevents the destruction of 
both M-phase (maturation)–promoting factor (MPF) activity 
(CDK1/cyclin B1) and cohesin, which holds sister chromatids 
together (Nixon et al., 2002; Madgwick et al., 2004). Resumption 
of meiosis in mammalian oocytes is achieved by a sperm-borne 
phospholipase C activity (Saunders et al., 2002; Knott et al., 
2005), which generates an oscillatory Ca
2+ signal, switching on 
APC
cdc20 (Nixon et al., 2002; Madgwick et al., 2004) through 
a signaling pathway involving calmodulin-dependent protein 
kinase II (CamKII; Markoulaki et al., 2003, 2004; Madgwick 
et al., 2005). This signaling process is conserved and was fi  rst 
demonstrated in frog eggs (Lorca et al., 1993, 1994). Activation 
of the APC in MetII oocytes induces the destruction of MPF 
and sister chromatid cohesion through the polyubiquitination of 
cyclin B1 and securin, respectively (Morgan, 1999; Zachariae 
and Nasmyth, 1999; Peters, 2002). Loss of cyclin B1 causes 
a reduction in MPF, and the loss of securin frees separase 
to act on the kleisin component of cohesin (Zachariae and 
  Nasmyth, 1999; Peters, 2002; Blow and Tanaka, 2005; Nasmyth 
and Haering, 2005).
Many proteins have been associated with the establishment 
and/or maintenance of CSF activity. Factors responsible for 
 setting up a second meiotic spindle after completion of meiosis I 
do not, a priori, have to be the same as those that are responsible 
for maintaining arrest. Indeed, proteins have been described 
that are involved in establishing MetII, but not in maintaining 
arrest once it has been achieved (Tunquist and Maller, 2003). 
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  D
uring interkinesis, a metaphase II (MetII) spindle 
is built immediately after the completion of mei-
osis I. Oocytes then remain MetII arrested until 
  fertilization. In mouse, we ﬁ  nd that early mitotic inhibi-
tor 2 (Emi2), which is an anaphase-promoting complex 
inhibitor, is involved in both the establishment and the 
maintenance of MetII arrest. In MetII oocytes, Emi2 needs 
to be degraded for oocytes to exit meiosis, and such deg-
radation, as visualized by ﬂ  uorescent protein tagging, 
  occurred tens of minutes ahead of cyclin B1.
Emi2 antisense morpholino knockdown during oo-
cyte maturation did not affect polar body (PB) extrusion. 
  However, in interkinesis the central spindle microtubules 
from meiosis I persisted for a short time, and a MetII spindle 
failed to assemble. The chromatin in the oocyte quickly de-
condensed and a nucleus formed. All of these effects were 
caused by the essential role of Emi2 in stabilizing cyclin 
B1 after the ﬁ  rst PB extrusion because in Emi2 knockdown 
oocytes a MetII spindle was recovered by Emi2 rescue or 
by expression of nondegradable cyclin B1 after meiosis I.
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The mechanism of CSF is most well characterized in the frog, 
where various groups have fi  rmly defi  ned the c-Mos–MAPK–
90-kD ribosomal protein S6 kinase (p90rsk)–budding uninhib-
ited by benzimidazole 1 (Bub1) pathway in establishing CSF 
activity (Sagata et al., 1989; Abrieu et al., 1996; Bhatt and 
  Ferrell, 1999; Gross et al., 1999, 2000; Tunquist et al., 2002). 
Other activities that are fundamentally involved in the estab-
lishment of CSF in frog include cyclin E/Cdk2 (Tunquist et al., 
2002) and mitotic arrest defi  cient 2 (Mad2; Tunquist et al., 
2003). However, once established, p90rsk, Mad2, Bub1, and 
cyclin E/Cdk2 are all dispensable for the maintenance of CSF 
activity (Bhatt and Ferrell, 1999; Tunquist et al., 2002, 2003).
So, how is CSF activity maintained in the frog? Current 
evidence suggests it is through early mitotic inhibitor 2 (Emi2)/
Emi-related protein 1 (Liu and Maller, 2005; Rauh et al., 2005; 
Schmidt et al., 2005; Tung et al., 2005; Hansen et al., 2006). Emi2, 
which acts to inhibit the APC accumulated during oocyte matura-
tion, is present and stable in CSF frog egg extracts, but is rapidly 
degraded on Ca
2+ addition (Schmidt et al., 2005).   Degradation of 
Emi2 is induced by phosphorylation through CamKII (Liu and 
Maller, 2005; Rauh et al., 2005; Hansen et al., 2006) and, thus, 
would be predicted to occur ahead of APC activation and cyclin 
B1 degradation, although this has not been tested.
In mouse oocytes, the mechanism of CSF arrest is less 
well understood. As the mouse Emi2 homologue appears to 
have a similar function in maintaining CSF activity (Shoji et al., 
2006), it would be logical to predict that the mechanism of 
CSF establishment is also conserved between frog and mouse. 
 However, this is not so. Oocytes from a triple Rsk (1,2,3) knockout 
mouse arrest normally at MetII (Dumont et al., 2005), demon-
strating that p90Rsk is not involved in mouse CSF arrest. 
  Furthermore, using dominant-negative mutants Tsurumi et al., 
(2004) confi  rmed that the spindle checkpoint proteins Bub1 and 
Mad2 are not required for either the establishment or the main-
tenance of mouse CSF. Although c-Mos is known to be involved 
in CSF maintenance, it does not appear to be involved in the 
 establishment of CSF arrest because c-Mos −/− oocytes  remain 
at MetII for 2–4 h before extruding a second PB (PB2; Verlhac 
et al., 1996).
As there are no fi  rm candidates suggested to be involved 
in the establishment of CSF arrest in mouse, we have investi-
gated the potential of mouse Emi2 in this process. We fi  nd that 
Emi2 has activity consistent with CSF, and its degradation in 
real time is ahead of any change in cyclin B1. We also demon-
strate that a function of Emi2 is in restabilizing cyclin B1 upon 
exit from anaphase I and that, in this study, it contributes to the 
formation a bipolar spindle. Oocytes matured without Emi2 do 
not assemble MetII spindles, and, in the absence of cyclin B1, 
eventually decondense their chromatin.
Results
Stable Emi2 is rapidly degraded by Ca
2+
To measure real-time changes in Emi2 levels in oocytes we gen-
erated cRNA to mouse Emi2 coupled to Venus fl  uorescent pro-
tein (Emi2-V), which is a yellow variant of GFP. MetII mouse 
oocytes were microinjected with this construct at a dose of ei-
ther 0.15 or 0.5 pg, and then cultured for a few hours to allow 
for Emi2 expression. We Western blotted oocytes expressing 
Emi2-V with a polyclonal antibody against Emi2 to determine 
the amount of Emi2-V expression relative to endogenous protein. 
More than one band was detected on oocyte blots using this 
  antibody; however, one band at  85 kD migrated at the same 
molecular mass as in vitro–translated Emi2 (and this band was 
later knocked down by Emi2 morpholino [MO]). At the 0.15-pg 
dose, Emi2-V levels were less than endogenous protein after 
2 h, whereas the 0.5-pg dose was expressed to about the same 
level as endogenous protein (Fig. 1 A). 
Emi2-V was very stable in MetII-arrested oocytes, but 
became rapidly unstable when cytosolic Ca
2+ increased. With 
either 0.15 pg (Fig. 1 B) or 0.5 pg (not depicted) injections, we 
observed no degradation of Emi2-V in MetII oocytes after block-
ing further synthesis by washing into   cycloheximide-  containing 
media. However, when this experiment was repeated, but by 
washing into Sr
2+-containing media to induce spermlike Ca
2+ 
spiking (Bos-Mikich et al., 1997), we observed dose-  dependent 
effects on Emi2-V. At the higher 0.5-pg dose, we observed no 
loss in Emi2-V signal; instead, Emi2-V levels steadily increased 
Figure 1.  Emi2-V is stable in MetII oocytes, 
but is rapidly degraded by Ca
2+. (A) Western 
blot of oocytes microinjected 2 h before with 
0.15 or 0.5 pg of Emi2-V. 35 oocytes were 
loaded per lane. Endogenous Emi2 and Emi2-V 
are marked. *, nonspeciﬁ  c band. (B) Emi2-V 
(0.15 pg cRNA) expression levels on addition 
of cycloheximide (CHX; n = 12). (C and D) 
Emi2-V (C, 0.5 pg cRNA; D, 0.15 pg cRNA) 
expression levels after washing into Sr
2+ 
  media at the times indicated (C, n = 14; D, 
n  = 15). (E) Cyclin B1-V (0.09 pg cRNA) 
  expression levels after washing into Sr
2+ media 
at the times indicated (n = 15). TE and TC repre-
sent the time from complete degradation of the 
Venus ﬂ  uorochrome (TE, Emi2; TC, cyclin B1) to 
PB2 extrusion in oocytes. PB2 was observed at 
the times indicated. A is representative of two 
independent Western blots. (B–E) are represen-
tative traces of n oocytes that have been used 
from two to four independent experiments.EMI2 AND MEIOSIS II ENTRY • MADGWICK ET AL. 793
(Fig. 1 C). However, at the lower 0.15-pg dose Emi2-V was rap-
idly degraded (Fig. 1 D).
The high dose of Emi2 maintained oocytes in a MetII 
  arrest. Oocytes injected with 0.5 pg Emi2-V cRNA showed no 
morphological signs of meiotic resumption, which is consistent 
with the maintained Emi2-V levels in these oocytes (Fig. 1 C). 
In contrast, oocytes that had been injected with 0.15 pg Emi2-V 
cRNA extruded a PB2 (Fig. 1 D). This suggests that Emi2-V 
has physiological CSF activity and that the oocyte has a fi  nite 
capacity to degrade Emi2.
Emi2 is degraded ahead of cyclin B1
At the lower dose Emi2 injection, where we observed Emi2-V 
degradation, the minimum in its degradation profi  le after activa-
tion with Sr
2+ media was reached tens of minutes before PB2 
extrusion (Fig. 1 D, TE). However, we have previously reported 
that cyclin B1 degradation, visualized by coupling to GFP, is 
only completed at the time of PB2 formation (Hyslop et al., 
2004). This suggests that the Emi2 and cyclin B1 degradation 
profi  les may not fully overlap. When cyclin B1 was expressed 
in mouse oocytes with the same fl  uorescent protein tag as Emi2 
(cyclin B1-Venus; cyclin B1-V), we observed the same degra-
dation profi  le as that previously found for cyclin B1-GFP, such 
that a minimum in the cyclin B1-V profi  le was reached within 
minutes of PB2 extrusion (Fig. 1 E, Tc).
Comparing the degradation profi  les of Emi2-V and cyclin 
B1-V suggests that Emi2 degradation is initiated ahead of cyclin 
B1. Sr
2+-induced Emi2 degradation begins immediately (Fig. 1 D), 
whereas that of cyclin B1 begins 20 min later (Fig. 1 E). This 
would have to occur if MetII arrest is being mediated by Emi2-
induced inhibition of APC
cdc20 activity. Therefore, we wanted to 
confi  rm the immediate loss of endogenous Emi2 signal in 
 oocytes, which is especially important given that Shoji et al. (2006) 
had reported very little loss in Emi2 signal at a 6-h time point 
  after activation with Sr
2+. Oocytes were activated by washing 
into Sr
2+ media, and samples from a pool of oocytes were removed 
at various time points and probed for either cyclin B1 or Emi2 
by Western blotting (Fig. 2 A). In these experiments, it was 
  apparent that loss in Emi2 protein was rapid and complete by 
30 min (in agreement with the rapid loss of Emi-V shown in 
Fig. 1 D). Interestingly, Emi2 levels increased again in pronu-
cleate embryos (6-h time point), which is in agreement with 
Shoji et al. (2006) and suggests that it may have a further mitotic 
function (see Discussion). Similar to Emi2, we observed the loss 
of cyclin B1 at 30 min, as well as increased levels in pronucleate 
embryos (Fig. 2 A), which is consistent with our observation that 
the APC is switched off at this time (Nixon et al., 2002).
Because of the numbers of oocytes needed for Western 
blots and the tens of minutes of asynchrony in timing at which 
Ca
2+ spiking starts with Sr
2+ media, (Madgwick et al., 2004), 
we could not reproducibly resolve Emi2 degradation ahead of 
cyclin B1 by Western blotting groups of oocytes. Therefore, to 
examine with more accuracy the immediate degradation pro-
fi  les of cyclin B1 and Emi2, we decided to measure their simul-
taneous degradation in the same oocyte. Cyclin B1 was coupled 
to Cerulean fl  uorescent protein (cyclin B1-C), which is a cyan 
variant of GFP. There was no overlap in Venus and Cerulean 
signals, showing that both Emi2-V and cyclin B1-C, with ap-
propriate fi  lters, could be imaged simultaneously in the same 
oocyte (Fig. 2 B). In these experiments, it was evident that the 
introduction of Emi2-V delayed cyclin B1 degradation (Fig. 1 E 
and Fig. 2 C), which is consistent with Emi2-inhibiting APC 
Figure 2.  Emi2 is degraded ahead of cyclin B1. (A) West-
ern blot (WB) of oocytes for Emi2 (top; n = 100 oocytes 
per lane) and cyclin B1 (n = 30 oocytes per lane), and 
corresponding membranes stained with Coomassie bril-
liant blue (CB) to show equivalent loading. Oocytes are 
activated by washing into Sr
2+ media for the times indi-
cated. (B) Epiﬂ  uorescence images of MetII oocytes micro-
injected with Emi2-V cRNA or cyclin B1-C cRNA, at the 
excitation wavelengths of Cerulean (430 nm) and Venus 
(500 nm). There is negligible overlap in signal between 
the two ﬂ  uorochromes, demonstrating that Emi2-V and cy-
clin B1-C may be imaged in the same oocyte. Bar, 20 μm. 
(C) Simultaneous Venus (yellow) and Cerulean (blue) ﬂ  uo-
rescence in a MetII oocyte expressing Emi2-V and cyclin 
B1-C, and washed into Sr
2+ media at time t = 0 min. 
Emi2-V degradation begins tens of minutes before that of 
cyclin B1. (A) The Western blot was repeated once with 
similar timings. C is representative of seven oocytes from 
two independent experiments.JCB • VOLUME 174 • NUMBER 6 • 2006  794
activity. However, these coexpression studies revealed that 
Emi2 degradation began tens of minutes before that of cyclin 
B1 (Fig. 2 C). Emi2-V levels were degraded by at least 50% 
  before the start of cyclin B1-C degradation (n = 7).
Emi2 degradation is independent 
of a spindle checkpoint
Degradation of cyclin B1 is dependent on APC
cdc20 activity, and 
in mouse oocytes it can be blocked by the induction of a spindle 
checkpoint (Nixon et al., 2002; Madgwick et al., 2005). In con-
trast, Emi2 degradation should be checkpoint-independent be-
cause its degradation is independent of APC
cdc20 involvement. 
Incubation of Emi2- and cyclin B1-expressing oocytes with the 
spindle poison nocodazole blocks mouse oocytes from exiting 
MetII arrest when washed into Sr
2+ media. As expected, the ad-
dition of nocodazole completely stabilized cyclin B1 levels 
(n = 15/15; Fig. 3 A). However, nocodazole had no effect on the 
rate of Emi2-V degradation (n = 12/12; Fig. 3 B). Such an ob-
servation is consistent with cyclin B1, but not Emi2 degrada-
tion, being dependent on the APC.
Therefore, in summary, we have obtained data that are en-
tirely consistent with a model of MetII arrest achieved by Emi2-
mediated inhibition of cyclin B1 degradation. Also, the Emi2-V 
construct generated is a physiologically active, useful tool for 
both establishing CSF activity and measuring its loss in real 
time after a Ca
2+ signal.
Oocytes with Emi2 knockdown extrude 
a PB, but do not MetII arrest
Emi2 levels are low in both Xenopus laevis and mouse oocytes 
before they are matured. This would be predicted, as high Emi2 
levels during maturation may be deleterious and arrest oocytes 
at MetI. The increased Emi2 expression during oocyte matura-
tion makes it highly likely that Emi2 expression can be knocked 
out by an antisense approach. Therefore, we designed an anti-
sense MO to the 5′UTR immediately adjacent to the start codon 
of mouse Emi2 (Emi2 MO) and used an additional two MO’s as 
controls (Table I); a 5-base mispair MO (5mp-MO), in which 
fi  ve bases have been altered from the complementary sequence, 
and an inverted MO (Inv-MO). 
To explore the role of Emi2 in the establishment of MetII 
arrest, we injected Emi2 MO into germinal vesicle (GV) 
  oocytes, which were then matured in vitro. Oocytes were held at 
the GV stage in milrinone-containing media for 2 h after MO 
injection; they were then released from GV arrest and allowed 
to mature for 16 h. Blotting of GV-stage oocytes, Emi2 MO–
matured oocytes, and uninjected control matured oocytes dem-
onstrated that Emi2 protein levels increase between GV and 
MetII stage, and confi  rmed the Emi2 knockdown in Emi2 MO–
injected oocytes (Fig. 4 A). 
During maturation, oocytes were scored for the morpho-
logical events of oocyte maturation, which are GV breakdown 
(GVBD) and PB1 extrusion (Fig. 4 B). Both GVBD (Fig. 4 C) 
and PB1 extrusion (Fig. 4 D) occurred with normal timings 
in Emi2 MO–injected oocytes. However, after maturation, we 
observed marked differences in the morphology of control 
oocytes and those injected with Emi2 MO. When control 
  oocytes (uninjected, 5mp-MO, and Inv-MO–injected) were 
stained for chromatin, oocytes were morphologically normal. 
They had a PB1 containing chromatin, which was produced 
on completion of the fi  rst meiotic division, and a fully formed 
MetII spindle (100%; uninjected oocytes, n = 60; 5mp-MO, 
n = 32; Inv-MO, n = 25; Fig. 5 A). However, although oocytes 
injected with Emi2 MO did have a PB1 containing chromatin, 
the chromatin in the oocyte was decondensed inside a nucleus 
(93%; n = 110; Fig. 5 A). 
Despite the lack of effect of a 5mp-MO, it remained 
  possible that we had been extremely unlucky in the MO design, 
such that the observed effects of Emi2 MO were caused by its 
ability to block the expression of an unrelated protein involved 
in MetII arrest. We thought this unlikely, given that a similar 
morphology of Emi2 knockdown oocytes has been reported re-
cently using a double-stranded RNAi approach (Shoji et al., 2006). 
Figure 3.  Emi2-V degradation is independent of a spindle checkpoint. 
  Venus ﬂ  uorescence levels in a MetII oocyte expressing cRNA to cyclin B1-V 
(A; n = 12) or Emi2-V (B; n = 15) after the addition of Sr
2+ media contain-
ing 100 ng/ml nocodazole at time t = 0 h. Both A and B are represent-
ative of oocytes collected in two independent experiments.
Table I.  Emi2 MOs used in this study
MO Sequence
Mouse Emi2 A GCC AGC CAC AGA GCA GGA AGC AAT 
ATG GAC TCC TCT
Emi2 MO ATT GCT TCC TGC TCT GTG GCT GGC T
5mp MO ATT CCT TGC TGC TGT GTG CCT GCC T
Inv MO TCG GTC GGT GTC TCG TCC TTC GTT A
Emi2 MO was designed to target the 5′UTR of mouse Emi2 (underlined). 
A 5mp MO and an Inv MO were used as control MOs.EMI2 AND MEIOSIS II ENTRY • MADGWICK ET AL. 795
However, we decided it was important to confi  rm the specifi  city 
by a rescue to the control phenotype in Emi2-MO–injected 
  oocytes by expression of exogenous Emi2. To recover Emi2, 
Emi2-V cRNA was microinjected into oocytes 2 h after micro-
injection of Emi2 MO and immediately before release from GV 
arrest. This rescue is made possible because Emi2-V lacks the 
5′UTR recognized by the MO.
Injection of Emi2-V cRNA alone into GV oocytes that 
were matured induced a MetI arrest (n = 40; Fig. 5 A), which is 
consistent with Emi2-V having CSF activity and the need to 
keep Emi2 levels low until completion of the fi  rst meiotic 
  division. Importantly, Emi2-V cRNA expression could rescue 
the effects of MO knockdown. Rescue oocytes could progress 
through meiosis I and arrest as controls with a fully formed 
MetII spindle. A high dose of Emi2-V (0.5 pg; n = 45) rescued 
the Emi2 MO phenotype, with an equal mix of either MetI or 
MetII arrest, whereas oocytes microinjected with the lower 
Emi2 dose showed a rescue with a predominantly MetII arrest 
(n = 45; Fig. 5 A).
Lack of Emi2 results in a failure 
to assemble a metaphase II spindle
By scoring oocytes for decondensed chromatin at only one 
time point (16 h), we were unable to pinpoint at which stage of 
meiosis oocytes undergo chromatin decondensation.   However, 
we noted that the vast majority of oocytes with decondensed 
chromatin extruded only a single PB and contained only one 
nucleus (88%; n = 102). This observation suggests either de-
condensation of chromatin occurred after anaphase I, such 
that oocytes did not form a MetII spindle (Fig. 5 B, i), or, 
alternatively, that after establishment of a MetII spindle there 
was no sister chromatid disjunction before decondensation 
(Fig. 5 B, ii).
We determined whether Emi2 MO knockdown oocytes 
were able to build a MetII bipolar spindle by staining oocytes 
for both chromatin and tubulin at various times after PB1 extrusion. 
Oocytes were fi  xed at 0.5, 1, and 2 h after PB1 extrusion. In 
control uninjected oocytes, central spindle microtubules were 
observed at 0.5 h after PB extrusion (Fig. 6 A), and over the next 
1.5 h a MetII spindle formed, such that by 2 h after PB1 a fully 
formed MetII spindle was found in all oocytes (Fig. 6 B). In 
Emi2-MO–injected oocytes, at 0.5 h after PB1 there was no dif-
ference from controls, with central spindle microtubules evident 
between the chromatin in the ooplasm and the PB1 (Fig. 6 A). 
However, in contrast to control oocytes, in Emi2-MO–injected 
oocytes at both the 1 and the 2 h time points we observed no 
MetII spindle; instead, the chromatin had remained essentially 
unaltered from the time of PB1 extrusion. The residual central 
spindle microtubules remained between the chromatin in the 
oocyte and the PB, and by 2 h the chromatin appeared to be 
  beginning to decondense (Fig. 6 B). As the chromatin started 
to decondense, spindle microtubule structure was lost, which 
is consistent with entry into interphase. By 6 h, all Emi2-MO–
injected oocytes had a single nucleus containing fully decon-
densed chromatin. We did not assess if these oocytes underwent 
S-phase; however, they showed no obvious signs of degenera-
tion over the 6-h time period from PB1 extrusion. Thus, we 
failed to observe the formation of a bipolar spindle in any Emi2-
MO–treated oocytes; instead, oocytes underwent full chromatin 
decondensation.
Emi2 stabilizes cyclin B1 after 
PB1 extrusion
Because the formation of a MetII spindle requires an increase in 
the levels of CDK1 activity after PB1 extrusion, we reasoned 
that in the absence of Emi2, levels of CDK1’s regulatory partner 
Figure 4.  GVBD and PB1 extrusion occur nor-
mally in Emi2 MO–injected oocytes. (A) West-
ern blot of GV-stage, Emi2 MO–  matured, 
and control matured oocytes; 75 oocytes 
were loaded per lane. *, nonspeciﬁ  c  band. 
(B) Brightﬁ  eld time lapse of an oocyte microin-
jected with Emi2 MO and allowed to mature. 
GVBD and PB1 are marked. Bar, 20 μm. The 
percentage rate of GVBD (C) and PB1 extru-
sion (D) at the times indicated for control oo-
cytes (n = 32) and oocytes microinjected with 
Emi2 MO (n = 33). The Western blot in A 
is representative of two independent experi-
ments. The data in C and D was pooled from 
two independent experiments.JCB • VOLUME 174 • NUMBER 6 • 2006  796
cyclin B1 may not be reestablished. To test this directly, Emi2 
MO or control GV oocytes were microinjected with cyclin 
B1-V cRNA and matured in vitro. Cyclin B1-V levels were 
monitored in real time during maturation, along with brightfi  eld 
microscopy to assess progression through meiosis I. As previ-
ously reported (Hyslop et al., 2004), in control oocytes there 
was a period of cyclin B1 degradation that lasted a few hours 
and was terminated on PB1 extrusion (Fig. 7 A). Immediately 
after PB1 extrusion in these oocytes, cyclin B1 levels rose to 
24.0 ± 1.1% (n = 14) of the peak level before PB1 extrusion 
(Fig. 7 B). In Emi2-MO–injected oocytes, there was no differ-
ence from controls in the timing of initiation or in the rate of 
  cyclin B1-V degradation during meiosis I, which is in agreement 
with the observed lack of effect of the MO on the timing of PB1 
(Fig. 4 D). However, in these Emi2 MO oocytes there was no 
reelevation of cyclin B1 after PB1 extrusion; cyclin B1-V levels 
increased to just 1.6 ± 0.3% (n = 15) of the peak level before 
PB1 extrusion (Fig. 7 B).
In keeping with the real-time effects on exogenous cyclin 
B1-V expression, we also observed a loss of endogenous cyclin 
B1 after Emi2 knockdown. In vitro–matured oocytes injected 
with Emi2 MO at the GV stage showed much lower cyclin 
B1 levels than control in vitro–matured oocytes (Fig. 7 C). 
Further  more, cyclin B1 levels in individual oocytes were mea-
sured by immunofl  uorescence at 16 h after release from GV 
  arrest in control and Emi2-MO–injected oocytes (Fig. 7, D and E). 
We found that cyclin B1 immunofl  uorescence levels in Emi2 
MO–treated oocytes was about one third that of control oocytes 
(Fig. 7 E), suggesting a relatively uniform level of knockdown.
Nondegradable cyclin B1 and Mad2 
rescue a bipolar spindle in Emi2 
knockdown oocytes
Because the formation of a MetII spindle requires an elevation 
in the levels of cyclin B1, we reasoned that the Emi2 MO spin-
dle defect may be recovered by the addition of cRNA to non-
degradable cyclin B1. Furthermore, it should also be rescued 
by inhibiting the APC
cdc20 by addition of Mad2. Cyclin B1 with 
deletion of 90 N-terminal amino acids (∆90 cyclin B1) lacks a 
D-box and is therefore not a substrate of the APC (Glotzer et al., 
1991; Madgwick et al., 2004). Emi2-MO–injected oocytes 
Figure 5.  Decondensed chromatin in Emi2 MO–injected matured oocytes. 
(A) Percentage of maturation rates in in vitro–matured oocytes after micro-
injection at the GV stage of MOs and/or Emi2-V cRNA, as indicated. 
  Oocyte maturation was assessed at 16 h after release from GV arrest. 
  Oocytes were stained with Hoechst and scored as either arrested at MetI 
or MetII or as having decondensed chromatin. (B) Emi2 MO oocytes typi-
cally extruded a PB1 and contained only one nucleus (88%; n = 102). This 
single nucleus must result through chromatin decondensation either imme-
diately after PB1 extrusion (i) or after the formation of a MetII spindle that 
fails to segregate its sister chromatids (ii). The data in A was pooled from 
12 independent experiments. See Oocytes with Emi2 knockdown extrude 
a PB, but do not MetII arrest.
Figure 6.  A bipolar MetII spindle does not form in Emi2 MO–injected 
  oocytes. Tubulin (red) and chromatin (blue) staining in either Emi2 MO–
  microinjected or control oocytes at 0.5 (A), 2 (B), or 6 h (C) after PB1 
  extrusion. (A) In control and Emi2 MO–injected oocytes, a central spindle 
forms between segregated homologues at 0.5 h. (B) By 2 h after PB1 extru-
sion, all control oocytes had a bipolar MetII spindle; however, Emi2 MO 
oocytes showed only microtubules that remained from the persistence of 
the central spindle. (C) By 6 h after PB1, chromatin in Emi2 MO–injected 
oocytes had completely decondensed inside a nucleus (N). Bar, 20 μm. 
Each image is representative of at least 10 oocytes. A–C are representa-
tive of two, three, and seven independent experiments, respectively.EMI2 AND MEIOSIS II ENTRY • MADGWICK ET AL. 797
either received no further treatment or were microinjected with 
1.5 pg ∆90 cyclin B1 or Mad2 cRNA within 15 min of PB1 
extrusion. This injection had to be done immediately after PB1 
extrusion because nondegradable cyclin B1 addition to oocytes 
before PB1, as predicted by the sustained MPF activity, blocks 
PB extrusion (Herbert et al., 2003). A few hours of ∆90   cyclin 
B1 cRNA expression generates cyclin B1 at a similar level 
to endogenous cyclin B1 in a MetII oocyte (Madgwick et al., 
2004). This dose of Mad2 causes a metaphase I arrest in matur-
ing oocytes (Homer et al., 2005) and prevents completion of 
meiosis in MetII oocytes (Madgwick et al., 2005). At 2 h after 
PB1 extrusion, all oocytes were fi  xed, stained, and scored for the 
presence of a bipolar spindle (Fig. 8 A). As observed in Fig. 6 B, 
oocytes microinjected with Emi2 MO gave decondensing chro-
matin with a lack of any bipolar spindle structure.   However, 
as with uninjected oocytes, we observed a fully formed   bipolar 
MetII spindle in oocytes microinjected with Emi2 MO and 
 either  ∆90 cyclin B1 cRNA or Mad2 (Fig. 8 B).
Discussion
We have demonstrated in live oocytes and in real time that upon 
a Ca
2+ signal, Emi2 degradation occurs ahead of cyclin B1, 
  independent of APC inhibition. The current study confi  rmed 
Figure 7.  Cyclin B1 levels remain low after 
PB extrusion in Emi2 MO–matured oocytes. 
(A) Venus ﬂ   uorescence levels in maturing 
  oocytes microinjected with cyclin B1-V cRNA 
(control) or cyclin B1-V cRNA and Emi2 MO. 
PB1 extrusion was observed at the times 
  indicated. Note the similar proﬁ   le of cyclin 
B1-V degradation in both oocytes, but the fail-
ure of cyclin B1-V levels to rise in the oocyte 
injected with Emi2 MO after PB1. (B) Quan-
tiﬁ   cation of the elevation in cyclin B1-V lev-
els after PB1 extrusion in the control oocytes 
(n = 14) and Emi2 MO oocytes (n = 15) used 
in A.   Endogenous cyclin B1 levels in matured 
oocytes detected by Western blotting (C) or 
immunoﬂ   uorescence (D and E). (C) A West-
ern blot (WB) for cyclin B1 in control matured 
oocytes and oocytes matured after microinjec-
tion of Emi2 MO at the GV stage (n = 40), 
and the corresponding membrane stained with 
Coomassie brilliant blue (CB) to demonstrate 
equivalent loading. In D, representative im-
ages of cyclin B1 levels in matured oocytes 
(control) and in matured oocytes microinjected 
at the GV stage with Emi2 MO detected using 
a TRITC-conjugated secondary antibody. Mean 
ﬂ   uorescence readings are marked for both 
oocytes on the 8-bit scale bar. (E) Quantiﬁ  ca-
tion of cyclin B1 immunoﬂ  uorescence levels in 
control (n = 25) and Emi2 MO–microinjected 
(n = 32) oocytes from D, relative to uninjected 
controls. A is representative of four indepen-
dent experiments whose data is pooled in B. 
(C) The Western blot was repeated once. D is 
representative of two independent experiments 
whose data is pooled in E.
Figure 8.  Emi2 MO phenotype recovery using 𝖫90   cyclin 
B1 or Mad2. (A) Percentage maturation rates in in vitro–
matured oocytes after no treatment (n = 12), or microin-
jection of Emi2 MO at the GV stage with or without further 
microinjection of ∆90 cyclin B1 or Mad2 after PB1 extru-
sion (Emi2 MO only, n = 20; with ∆90 cyclin B1, n = 25; 
or with Mad2, n = 35). Oocytes were ﬁ  xed and stained 
2 h after PB1 extrusion and scored for a bipolar spindle. 
(B) Tubulin (red) and chromatin (blue) staining in an   oocyte 
microinjected with Emi2 MO at the GV stage and then 
∆90 cyclin B1 cRNA 15 min after PB1 extrusion. Image is 
representative of 20/25 oocytes. Bar, 20 μm. Data is 
pooled from two independent experiments.JCB • VOLUME 174 • NUMBER 6 • 2006  798
that Emi2 constitutes CSF activity in mouse MetII oocytes and 
is responsible for the maintenance of MetII arrest (Shoji et al., 
2006). More importantly, we fi  nd that Emi2 is necessary and 
suffi  cient in stabilizing cyclin B1 levels at the completion of 
meiosis I, and such stabilization is essential in establishing a 
 bipolar  spindle.
By defi  nition, CSF activity must accumulate during oo-
cyte maturation, inhibit APC
cdc20 activity at MetII, and be inac-
tivated on a Ca
2+ signal at fertilization. Although only recently 
identifi  ed, the F-box protein Emi2 is very likely to constitute 
CSF in frog eggs (Liu and Maller, 2005; Rauh et al., 2005; 
Schmidt et al., 2005; Tung et al., 2005; Hansen et al., 2006). 
Emi2 inhibits the ubiquitin ligase activity of the APC
cdc20 
in   vitro, and in keeping with the nature of CSF, it accumulates 
during oocyte maturation, is present in CSF extracts, and is 
  rapidly degraded by Ca
2+ (Schmidt et al., 2005).
Maintenance of MetII arrest
We tested the characteristics of the mouse Emi2 homologue in 
MetII mouse oocytes. This achieved two goals. First, it allowed 
us to demonstrate that Venus-tagged Emi2 is physiologically 
active, and second, it provided us with data relating to the tim-
ing of Emi2 degradation on activation. Excess X. laevis Emi2 
protein prevents Ca
2+-induced CSF release in egg extracts 
(Schmidt et al., 2005); similarly, our MetII-arrested mouse oo-
cytes were refractory to Ca
2+ through modest rises in Emi2-V. 
A lower Emi2-V dose, less than endogenous protein, did not 
block escape from MetII arrest and allowed us to demonstrate 
that Emi2 is degraded ahead of cyclin B1. If Emi2 inhibits the 
APC in MetII arrest, it follows that Emi2 destruction must oc-
cur before the APC’s accelerated degradation of cyclin B1. 
I  ndeed, when both were simultaneously imaged in an oocyte 
  after a Ca
2+ rise, Emi2 was degraded by at least 50% before 
  cyclin B1. An anti-Emi2 antibody also revealed Emi2 protein 
in pronucleate embryos, which is in agreement with the obser-
vations of Shoji et al. (2006), demonstrating that Emi2 reaccu-
mulates in one-cell embryos and, thus, interestingly, may have 
a mitotic function. We have previously reported on Ca
2+ spiking 
during the fi  rst mitotic division of mouse embryos (Kono et al., 
1996), suggesting that in this study Emi2 may be degraded by 
a similar Ca
2+-dependent process.
In MetII-arrested mouse oocytes, the APC is already ac-
tive, but the addition of a Ca
2+ signal speeds up cyclin B1 deg-
radation sixfold through an increase in APC activity (Nixon 
et al., 2002). In mouse, the high levels of cyclin B1 required for 
MetII arrest are therefore achieved through equilibrium between 
synthesis and degradation (Kubiak et al., 1993). Induction of a 
spindle-assembly checkpoint by nocodazole prevents cyclin B1 
degradation, with or without the presence of a Ca
2+ signal 
(Nixon et al., 2002), showing that in mouse oocytes APC activ-
ity can be held in check by both CSF and a spindle-assembly 
checkpoint. In mouse, the spindle-assembly checkpoint is dis-
tinct from CSF (Tsurumi et al., 2004). In contrast to cyclin B1, 
we found little evidence of Emi2 protein turnover in MetII-
  arrested oocytes, suggesting that Emi2 itself is not a substrate of 
the APC. Indeed, upon a Ca
2+ signal, destruction of X. laevis 
Emi2 has been shown to occur via the phosphorylation of a 
known SCF
β-TRCP (Skp1-Cullin-F-box
β-TRCP) motif (DSGX3S) 
and not the APC (Rauh et al., 2005; Tung et al., 2005).
Establishment of MetII arrest
We used a MO antisense oligonucleotide to ablate the Emi2 rise 
during mouse oocyte maturation and confi  rmed a knockdown 
by Western blotting. By blocking the accumulation of Emi2, 
we have demonstrated that it is essential for stabilizing cyclin 
B1 after MetI during interkinesis, and therefore essential for the 
formation of a MetII spindle. Because of the known inhibitory 
action of Emi2 on APC activity, we interpret this observation to 
mean that in the absence of Emi2, the APC remains active, and 
thus cyclin B1 is continuously degraded. In agreement with this 
is our observation that nondegradable cyclin B1, but not full-
length cyclin B1, rescues a MetII arrest after Emi2 knockdown 
(Fig. 7 vs. Fig. 8), as does the APC
cdc20 inhibitor Mad2. The cur-
rent data have not ruled out some effect of Emi2 on cyclin B1 
synthesis. However, if so, Emi2 would also be able to negatively 
regulate expression of the microinjected cyclin B1 cRNA (Fig. 7). 
This lacks the cyclin B1 gene 3′UTR, which is important for 
regulating translation through polyadenylation (Tay et al., 2000). 
Therefore, we would argue that Emi2 is most likely affecting the 
rate of cyclin B1 degradation, rather than synthesis.
The observed Emi2 MO phenotype, PB1 extrusion and 
decondensed chromatin within a single pronucleus, was not 
caused by a nonspecifi  c effect of the MO for two reasons. First, 
we used two control MOs that were without effect. Second, we 
rescued the Emi2 knockdown by readdition of Emi2 cRNA, 
an approach that was made possible by the fact that the res-
cue cRNA did not contain the 5′UTR recognized by the MO. 
In some instances, especially where rescue was done with the 
higher dose of Emi2, oocytes went on to arrest at MetI. This 
would be consistent with Emi2 inhibiting the APC at this 
time and the requirement for APC activity in order for mouse 
oocytes to complete the fi  rst meiotic division (Herbert et al., 
2003; Terret et al., 2003; Hyslop et al., 2004; Homer et al., 
2005). Interestingly, the effect of Emi2 knockdown on oocyte 
maturation is the same as that obtained when expression of 
cyclin B1 is prevented by antisense during oocyte maturation 
(Ledan et al., 2001). In oocytes matured with cyclin B1 anti-
sense, MPF activity is not reestablished after PB1 extrusion, 
and a single pronucleus forms.
The Emi2 phenotype observed on in vitro–matured oocytes 
to some extent resembles the siRNA Emi2 knockdown pheno-
type obtained previously (Shoji et al., 2006), with decondensed 
chromatin in the parthenote. In that study, however, there was 
no analysis made of the spindle during the normal time course 
of maturation; instead, observations were made some 30 h after 
microinjection. Therefore, in such circumstances it was not pos-
sible to judge how the oocyte was progressing through meiosis I, 
for example if a MetII spindle formed and remained stable for 
some hours before extruding a PB and exiting meiosis II. Also, 
the diffi  culty in interpretation at this single time point was exac-
erbated in this strain of mouse by the degeneration of the PB1 
during the 30-h period.
The present experiments were designed to examine in 
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It was found that Emi2 was essential to restabilize cyclin B1 
during interkinesis, and this rise in cyclin B1 was necessary to 
build a bipolar spindle. This is a previously unreported role for 
Emi2 in either frog or mouse and may add clarity to the function 
of CSF in mouse. Given that species-specifi  c differences appear 
to exist, it is unclear whether this role in establishing MetII 
  arrest would be conserved in frog. In frog, several studies have 
elegantly identifi  ed the c-Mos–MAPK–p90rsk–Bub1 pathway 
(Sagata et al., 1989; Kosako et al., 1994; Bhatt and Ferrell, 
1999; Gross et al., 1999, 2000; Tunquist and Maller, 2003) and 
the spindle checkpoint proteins Mad1 and Mad2 as essential for 
the establishment of MetII arrest (Tunquist et al., 2003). Once 
established, Emi2 contributes to the maintenance of MetII 
arrest (Liu and Maller, 2005; Rauh et al., 2005; Schmidt et al., 
2005; Tung et al., 2005; Hansen et al., 2006), and is perhaps 
also required for the establishment of MetII arrest; however, 
this requires further investigation.
When compared with reports in frog, the mechanism of 
the establishment of MetII arrest in mouse is poorly understood. 
In contrast to frog, there have been no fi  rm candidates suggested 
to be involved in establishment. Oocytes from c-Mos −/− mice 
initially arrest at MetII for 2–4 h, but then fail to maintain 
this arrest and exhibit spontaneous parthenogenetic activation 
(Colledge et al., 1994; Hashimoto et al., 1994; Verlhac et al., 
1996). Verlhac et al. (1996) demonstrated convincingly that 
although c-Mos is required for the stabilization of MPF once 
MetII is achieved, neither c-Mos nor MAPK are involved in 
MPF reactivation during the MetI–MetII transition. These data 
suggest that c-Mos is part of the maintenance of MetII arrest, 
but not its establishment. In agreement with this, the addition 
of MAPK inhibitors to MetII oocytes induces parthenogenetic 
activation (Phillips et al., 2002). Therefore, it is clear that the 
c-Mos–MAPK pathway contributes to MetII arrest once it is 
established. In any event, MAPK activity declines after cyclin 
B1 degradation, so MAPK is not targeted immediately by the 
Ca
2+ signal at fertilization (Verlhac et al., 1994). Similarly, the 
main downstream target of MAPK activity in frog appears to 
have little role in MetII arrest in mouse because oocytes from 
p90rsk knockout mice (Dumont et al., 2005) still arrest at MetII. 
Furthermore, oocytes injected with dominant-negative forms 
of Bub1 and Mad2 still arrest at MetII (Tsurumi et al., 2004), 
suggesting that spindle checkpoint proteins are not involved in 
MetII arrest in mouse.
Although not involved in the establishment of MetII arrest, 
MAPK still appears to have a role in mouse oocytes before the 
formation of a MetII spindle through a MAPK-interacting and 
spindle-stabilizing protein (MISS; Lefebvre et al., 2002). MISS 
is present at meiosis I, but only becomes stable in meiosis II, 
where it is essential for the maintenance of spindle integrity. 
Oocytes maturing in the absence of MISS reach MetII arrest, but 
with severe spindle disorganization, including monopolar spin-
dles, numerous asters in the cytoplasm, or no spindle (Lefebvre 
et al., 2002). However, because spindle defects in these oocytes 
are not associated with a drop in cyclin B1 levels or histone H1 
activity, it is suggested that MISS does not have a direct role in 
CSF arrest. Instead, MISS plays a role in microtubule dynamics 
through an interaction with a microtubule-associated protein.
Previously, all CSF candidates demonstrated in frog ap-
peared to play either no role in CSF activity in mouse or are 
involved in only the maintenance of arrest once a MetII spin-
dle is established. In this study, we have demonstrated that in 
the absence of Emi2, mouse oocytes fail to form a bipolar 
MetII spindle and, thus, fail to establish MetII arrest because 
of an inability to elevate cyclin B1 levels in interkinesis. 
Therefore, these data, together with rescue of the Emi2 MO 
phenotype using exogenous ∆90 cyclin B1 added after PB1 
extrusion, imply that the driving force in establishing a   bipolar 
spindle at the end of meiosis is a restabilization of cyclin B1 
by Emi2.
Materials and methods
All chemicals were obtained from Sigma-Aldrich, unless otherwise stated, 
and were of tissue culture or embryo-tested grade where appropriate.
Gamete collection and culture
4–6-wk-old MF1 mice (Harlan) were used. GV oocytes and MetII oocytes 
were collected from hormonally primed animals, as previously described 
(Nixon et al., 2002; Hyslop et al., 2004). For bench handling, microinjec-
tions, and imaging experiments, GV oocytes and MetII oocytes were cul-
tured in medium M2. When necessary, oocytes were arrested at the GV 
stage in medium M2 containing 1 μM milrinone. For longer term incuba-
tion, GV oocytes and maturing oocytes were held in a 5% CO2-humidiﬁ  ed 
incubator at 37°C and cultured in MEM (Invitrogen) with 20% fetal calf serum. 
Parthenogenetic activation of MetII oocytes was achieved by washing 
oocytes into Ca
2+-free M2 media containing 10 mM SrCl2 (Bos-Mikich 
et al., 1997; Madgwick et al., 2004). Cycloheximide was added to media 
at a concentration of 10 μg/ml, and nocodazole was added at a concen-
tration of 100 nM. In the case of nocodazole, oocytes were incubated for 
15 mins before parthenogenetic activation.
Microinjection and imaging
Microinjection of MOs and cRNA constructs were made as described pre-
viously on the heated stage of an inverted microscope (TE300; Nikon) 
ﬁ  tted for epiﬂ  uorescence (Nixon et al., 2002). In brief, fabricated micro-
pipettes were inserted into cells using the negative capacitance overcom-
pensation facility on an electrophysiological ampliﬁ   er (World Precision 
Instruments); this procedure ensures a high rate of survival (>90%). Images 
were recorded using a 20× objective, NA 0.75, and a charge-coupled 
device camera (Micromax 1300Y; Sony). Filter sets were 430 ±10 nm
and 500 ±10 excitation ﬁ   lters for Cerulean and Venus, respectively 
  (Coherent) with a CFP/YFP 51017 BS&M dichroic mirror and emission 
  ﬁ  lter (Chroma Technology Corp.). Hoechst staining was examined using 
a 360 ±10.9 nm excitation ﬁ   lter (Chroma Technology Corp.). All live 
cell imaging was performed in medium M2 at 37°C. Confocal sections of 
Hoechst and Texas red staining were performed on a confocal microscope 
(SP2; Leica) to capture images of the spindle microtubules and chromatin. 
MetaMorph and MetaFluor imaging software (Universal Imaging Corp.) 
were used for image capture and data analysis.
cRNA constructs and MOs
Using primers speciﬁ   cally for the mouse homologue of the Emi2 gene 
(AK030012; National Center for Biotechnology Information), we ampli-
ﬁ  ed full-length mouse Emi2 by PCR from a mouse MetII-arrested oocyte 
cDNA library. In brief, the cDNA library was prepared by collecting 750 
MetII oocytes in sterile PBS. Oocytes were lysed immediately, and mRNA 
was isolated directly using a commercial kit according to the manufactur-
ers instruction (Dynabeads mRNA Direct kit; Dynal). Double-stranded 
cDNA was synthesized from RNA and ampliﬁ  ed by PCR using a cDNA 
synthesis kit (SMART PCR cDNA Synthesis kit; CLONTECH Laboratories, 
Inc.). Mouse Emi2 was then cloned from the cDNA library into a modiﬁ  ed 
pRN3 vector, designed to produce mRNA transcript C-terminally coupled 
to Venus. Full-length cyclin B1 and ∆90 cyclin B1 were ampliﬁ  ed by PCR 
as previously described (Madgwick et al., 2004). Full-length cyclin B1 was 
cloned into two modiﬁ  ed pRN3 vectors designed to produce mRNA tran-
scripts C-terminally coupled to Venus or Cerulean; ∆90 cyclin B1 was 
cloned into a nonﬂ  uorescent pRN3 vector (Madgwick et al., 2004). Mad2 
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stability was conferred in all constructs by the presence of a 5′ globin UTR 
upstream and both 3′UTR and poly (A)–encoding tracts downstream of the 
gene. cRNA was synthesized using T3 mMESSAGE mMACHINE (Ambion) 
and dissolved in nuclease-free water to the required micropipette concen-
tration. An antisense MO (Genetools) was designed to recognize the 
5′UTR of Emi2. Two further controls were also designed, the invert of this 
region and a 5mp (for sequences see Table I). All MOs were used at a 
  micropipette concentration of 2 mM.
Anti-Emi2 antibody puriﬁ  cation
An MBP fusion of the human Emi2 N terminus (residues 1–400; hEmi2N) 
and a GST fusion of the mouse Emi2 N terminus (residues 1–398; mEmi2N) 
were bacterially expressed and puriﬁ  ed using standard protocols, with the 
exception that all procedures involving GST-mEmi2N were conducted in 
the presence of 0.01% Triton X-100 to maintain protein solubility. Sera 
from rabbits immunized against MBP-hEmi2N were screened for immuno-
blot cross-  reactivity toward in vitro-translated mouse Emi2. GST-mEmi2N, 
immobilized on a column of CNBr-activated Sepharose 4B (17–0430-01; 
GE Healthcare), was used to afﬁ   nity purify anti-mEmi2 antibodies from 
cross-reactive sera. Antibodies were eluted from the column using 100 mM 
glycine, pH 2.5.
Immunoblotting
For Emi2, lysates from oocytes were incubated overnight with anti-mEmi2 
in the range of 2.5 to 10 μg/ml. Nonfat milk (5%) was used as a blocking 
solution. Anti–rabbit IgG (P0448; DakoCytomation; Figs. 1 and 2; NA934; 
GE Healthcare; Fig. 4) and ECL Plus (RPN2132; GE Healthcare) were used 
as secondary detection reagents.
For cyclin B1, lysates from oocytes were incubated overnight with 
anti-cyclin B1(1:400; Abcam; ab72). Nonfat milk (5%) was used as a 
blocking solution. Anti–mouse IgG (P0447; DakoCytomation) and ECL Plus 
were used as secondary detection reagents.
Immunostaining of oocytes
Immunostaining of cyclin B1 was performed as previously described (Reis 
et al., 2006). In brief, oocytes were ﬁ  xed and permeabilized by an incuba-
tion in 3.7% paraformaldehyde in PBS (30 min), followed by incubation in 
3.7% paraformaldehyde, 2% Triton X-100 in PBS (30 min). Fixed oocytes 
were then washed extensively in 1% PVP and 1% BSA in PBS. For spindle 
staining, oocytes were incubated with rat anti-tubulin antibody (YL1/2, 
1:40, Abcam). 5 μg/ml Texas red conjugated anti–rat goat IgG (Abcam) 
was used as a secondary antibody. To stain chromatin, oocytes received 
an additional incubation in 10 μg/ml Hoechst 33258. For cyclin B1 stain-
ing, oocytes were incubated with mouse anti-cyclin B1 antibody (1:400; 
Abcam). TRITC-conjugated anti–mouse rabbit IgG/IgM/IgA was used as 
a secondary antibody (1:40; DakoCytomation).
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